Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain
about
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptorCholinergic imaging in dementia spectrum disordersQuantitative measurement of cerebral acetylcholinesterase using.Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity.Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromesInitial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.PET imaging of fatty acid amide hydrolase with [(18)F]DOPP in nonhuman primates.Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.Radiosynthesis and evaluation of [¹¹C-carbonyl]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography.Mapping human brain fatty acid amide hydrolase activity with PET.Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.Noninvasive k3 estimation method for slow dissociation PET ligands: application to [11C]Pittsburgh compound B.Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.PET probes for imaging brain acetylcholinesterase.Cholinergic depletion and basal forebrain volume in primary progressive aphasia.Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT.Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.Non-MAO A binding of clorgyline in white matter in human brain.Dual-[11C]tracer single-acquisition positron emission tomography studies.Evaluation of simplified kinetic analyses for measurement of brain acetylcholinesterase activity using N-[11C]Methylpiperidin-4-yl propionate and positron emission tomography.Signal separation and parameter estimation in noninvasive dual-tracer PET scans using reference-region approaches.An improved radiosynthesis of O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate: A first-in-class cholinesterase PET tracer.Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.Voxel level quantification of [11C]CURB, a radioligand for Fatty Acid Amide Hydrolase, using high resolution positron emission tomography.PET measurement of brain acetylcholinesterase activities in cortex and subcortical areas.
P2860
Q24680848-08FDAF2C-A116-4ADC-8F8E-97D6BBDAEF2AQ26764933-744783AD-B6A7-4864-A8CB-2D2FACD44093Q31930863-18FB1568-1257-4B9D-A374-0B41459833C3Q31930873-C7771AD2-DDBC-4629-A6F0-2C01925C2AD4Q33853330-340F1920-94DE-48E2-9AD6-655083B236F9Q33905597-B7A9E082-635C-4FCF-B6E1-A26A8FED8FB9Q34473739-319310DA-D2CF-4C28-B395-7D7135EA13FBQ35486482-F53D1A72-B50F-43EE-B945-6F97D3F389D3Q35498087-30C60F87-DD19-4CF7-ADE3-289B900E4EA3Q36530102-CC4E209B-9918-4768-B2E7-2A05F77E8350Q36655387-5AE3C963-6090-4BD7-A511-9FA5720A3EEAQ37056546-54B93B80-5F68-4CAF-AFB2-BDAF61E9B46EQ37325526-E9A04F1E-FE15-4F93-BC5A-91C17E4125E1Q37625102-ACBCC06A-B04B-426D-A6C3-C278B879DE4DQ38166972-AEDF0E5E-9FC6-43CF-8DDA-841B0E3FF3A8Q38383122-C9B1E22A-E298-4220-A5D2-1D89BC1F1C0CQ41862863-B6A4EEF5-A49A-4629-A40A-B66787239BBFQ42544957-1842761E-E9DE-42FC-8057-0A0DAD1C570DQ43570515-A09C0198-C569-4608-9DDA-7E5E84D24307Q43794823-74F8C59C-3EB9-4E30-8E70-8077C36F4328Q43820029-4FD9FB7F-CC06-4982-AEAF-E52B7F0C3EDFQ43820431-188AF0C2-A0E0-4F2F-9380-00EB20ED018FQ44924584-2AEACF7D-0A53-46D0-9077-4669E889CD40Q46032798-24004C2C-E65D-4F6A-87A5-B1417C29804CQ46251426-7366CFE3-AB54-41DD-8A4C-C67F342F7931Q46513880-3C7DFC3D-9366-4397-933F-12687CE0E3DBQ50000433-9301AA18-97DE-4EE4-967F-7B185625B87FQ52146961-53AA0AED-20F4-48B7-8AD9-F3A322F8B132
P2860
Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@ast
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@en
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@nl
type
label
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@ast
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@en
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@nl
prefLabel
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@ast
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@en
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@nl
P2093
P2860
P1476
Kinetic modeling of N-[11C]met ...... terase activity in human brain
@en
P2093
P2860
P304
P356
10.1097/00004647-199910000-00012
P407
P577
1999-10-01T00:00:00Z
P5875
P6179
1006532706